查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553945

拉伸治療市場規模、佔有率、趨勢分析報告：依治療方法、地區、細分市場預測，2024-2030

Stretch Marks Treatment Market Size, Share & Trends Analysis Report By Treatment (Topical Products, Laser, Microdermabrasion, Oils & Serums), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

拉伸治療市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球拉伸治療市場規模將達到5.2913億美元，2024年至2030年複合年成長率為9.0%。

女性對妊娠期拉伸治療的認知不斷提高，這是成長的主要動力。此外，青少年拉伸的盛行率預計不斷上升，將刺激對其治療的需求。

北美擁有大量肥胖人口，這是該地區市場的主要動力。這是參與者擴大消費者目標並加強市場影響力的機會。此外，該地區主要參與者的增加也是一個競爭因素，對拉伸治療市場有正面影響。

越來越多的線上入口網站銷售治療拉伸的局部產品，這對玩家來說也是一個機會。因此，主要參與者可以透過這些線上入口網站增加銷售額並擴大產品系列。此外，消費者對外用產品的偏好正在增加需求並影響市場。

新產品發布數量的增加以及合作夥伴關係和創新等成長策略的採用是市場趨勢。亞太地區的經濟成長和消費者消費能力的提高也對市場成長產生正面影響。

拉伸治療市場報告亮點

  • 由於懷孕、肥胖、生雙胞胎或大嬰兒、體重快速減輕或增加等引起的拉伸病例不斷增加，局部產品已成為主要細分市場。
  • 由於需求旺盛、消費者可支配收入增加以及乳霜促銷力度加大，銷量增加，預計面霜細分市場在預測期內將出現顯著成長。
  • 飛梭雷射領域預計將在預測期內顯著成長，因為它是一種改善膚色、減少常見老化徵兆和增強皮膚紋理的產品。
  • 脈衝晶粒雷射領域也在顯著發展，因為患者的安全得到了完全的保證，不需要麻醉，因為機器在發射脈衝之前會產生冷噴霧，而且我在做的時候沒有疼痛感。
  • 由於可支配收入的增加、生活方式的改變以及網路購物網站的出現，亞太地區成為拉伸治療市場的主導部分。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章全球拉伸治療市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 拉伸治療市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章拉伸治療市場：按治療分類的估計和趨勢分析

  • 拉伸治療市場：治療儀表板
  • 拉伸治療市場：治療變化分析
  • 2018-2030 年拉伸治療市場規模及預測與趨勢分析（依治療方式）
  • 局部產品
  • 雷射
  • 微晶換膚

第5章拉伸治療市場：按國家和治療區域進行的估計和趨勢分析。

  • 全球拉伸治療市場：區域儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第6章 競爭狀況

  • 主要製造商的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • Alliance Pharma PLC
    • Basq Skincare
    • Clarins Group
    • Candela Corporation
    • Dermaclara Inc.
    • ET Browne Drug Co. Inc.（Palmers）
    • Helix BioMedix Inc.
    • HRA Pharma
    • Laboratoires Expanscience
    • Union Swiss（Pty）Ltd
    • Weleda AG Source
Product Code: GVR-2-68038-977-7

Stretch Marks Treatment Market Growth & Trends:

The global stretch marks treatment market size is expected to reach USD 529.13 million by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing awareness among women regarding the treating stretch marks caused during pregnancy is significantly driving the growth. Also, the growing prevalence of stretch marks in adolescents and teenagers is predicted to fuel the demand for their treatment.

High number of obese population in North America is majorly driving the market in the region. This is an opportunity for the players for expanding their consumer target and strengthening their market presence. Moreover, the increasing number of key players in the region is another factor driving the competition, thereby positively influencing the stretch marks treatment market.

Growing number of online portals for the sale of topical products for treating stretch marks is another opportunity for the players. The key players can thus, increase their sale through these online portals and expand their product portfolio. Moreover, consumer preference for topical products is augmenting its demand, thus affecting the market.

Rise in the launch of new products and adoption of growth strategies, such as partnerships and innovations are trending in the market. Growing Asia Pacific economies and rise in spending power of consumers in these regions is also influencing the market growth positively.

Stretch Marks Treatment Market Report Highlights:

  • Topical products is the leading segment owing to increasing cases of stretch marks caused due to pregnancy, obesity, history of delivering twins or large babies, pale skin, sudden weight loss or gain, and others
  • Creams segment is expected to grow considerably during the forecast period owing to increased sales due to high demand, rise in disposable income of consumers, and increased promotion of creams
  • Fractional laser segment is expected to grow substantially over the forecast period, since these products improve the skin tone, reduce the common signs of aging, and enhance the skin texture
  • Pulse-dye lasers domain is also growing significantly due to completely safety assurance for the patients, no need of anesthesia since the machine produces cold spray just before pulsing, eliminating the pain sensation
  • Asia Pacific is the dominant segment in the stretch marks treatment market owing to increasing disposable income, changing lifestyle, and emerging online shopping portals

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment Segment
    • 2.2.2. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Stretch Marks Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of obesity globally
      • 3.2.1.2. Rising number of pregnancies and concerns about stretch marks
      • 3.2.1.3. Advancements in treatment technologies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of the advanced treatment
      • 3.2.2.2. Risk of side effects and complications
  • 3.3. Stretch Marks Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Stretch Marks Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Stretch Marks Treatment Market: Treatment Dashboard
  • 4.2. Stretch Marks Treatment Market: Treatment Movement Analysis
  • 4.3. Stretch Marks Treatment Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Topical Products
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Creams
      • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. Oils & Serums
      • 4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4. Lotions
      • 4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Laser
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Fractional Laser
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Pulse-Dye Laser
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1 Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Microdermabrasion
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Stretch Marks Treatment Market: Regional Estimates & Trend Analysis by Country, Treatment.

  • 5.1. Global Stretch Marks Treatment Market: Regional Dashboard
  • 5.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 5.3. North America
    • 5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key country dynamics
      • 5.3.4.2. Regulatory framework/ reimbursement structure
      • 5.3.4.3. Competitive scenario
      • 5.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Key country dynamics
      • 5.4.9.2. Regulatory framework/ reimbursement structure
      • 5.4.9.3. Competitive scenario
      • 5.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.3. Japan
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Regulatory framework/ reimbursement structure
      • 5.5.7.3. Competitive scenario
      • 5.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.7.3. South Africa
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework/ reimbursement structure
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2023
    • 6.3.4. Alliance Pharma PLC
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Basq Skincare
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Clarins Group
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Candela Corporation
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Dermaclara Inc.
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. E.T. Browne Drug Co. Inc. (Palmers)
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Helix BioMedix Inc.
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. HRA Pharma
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Laboratoires Expanscience
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Union Swiss (Pty) Ltd
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. Weleda AG Source
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Product benchmarking
      • 6.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 4 Global stretch marks treatment market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 7 U.S stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 8 Canada stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 9 Mexico stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 10 Europe stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 UK stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 13 Germany stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 14 France stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 15 Italy stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 16 Spain stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 17 Denmark stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 18 Sweden stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 Norway stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 22 Japan stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 23 China stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 24 India stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 Australia stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 26 Thailand stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 South Korea stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 28 Latin America stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 29 Latin America stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 30 Brazil stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 31 Argentina stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 32 MEA stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 33 MEA stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 34 South Africa stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 UAE stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 37 Kuwait stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 Participant's overview
  • Table 39 Financial performance
  • Table 40 Key companies undergoing expansions
  • Table 41 Key companies undergoing acquisitions
  • Table 42 Key companies undergoing collaborations
  • Table 43 Key companies launching new types/services
  • Table 44 Key companies undergoing partnerships
  • Table 45 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Stretch marks treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain - based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Stretch marks treatment market revenues, 2023, (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Stretch marks treatment market treatment outlook:
  • Fig. 14 Stretch marks treatment market: reatment movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global creams market, 2018 - 2030 (USD Million)
  • Fig. 17 Global oils & serums market, 2018 - 2030 (USD Million)
  • Fig. 18 Global lotions market, 2018 - 2030 (USD Million)
  • Fig. 19 Global laser market, 2018 - 2030 (USD Million)
  • Fig. 20 Global fractional laser market, 2018 - 2030 (USD Million)
  • Fig. 21 Global pulse - dye laser market, 2018 - 2030 (USD Million)
  • Fig. 22 Global others market, 2018 - 2030 (USD Million)
  • Fig. 23 Global microdermabrasion market, 2018 - 2030 (USD Million)
  • Fig. 24 Regional market place: Key takeaways
  • Fig. 25 North America stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 31 UK stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 32 France stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 Asia Pacific stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 36 Japan stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 37 China stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 38 India stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 39 Australia stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 40 Latin America stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 41 Brazil stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 MEA stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 43 South Africa stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Saudi Arabia stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 45 Market Participant Categorization
  • Fig. 46 Strategy mapping